anandamide endocannabinoid
Selected indexed studies
- Anandamide and endocannabinoid system: an attractive therapeutic approach for cardiovascular disease. (Ther Adv Cardiovasc Dis, 2018) [PMID:29764302]
- Anandamide and other N-acylethanolamines: A class of signaling lipids with therapeutic opportunities. (Prog Lipid Res, 2023) [PMID:36150527]
- An Introduction to the Endogenous Cannabinoid System. (Biol Psychiatry, 2016) [PMID:26698193]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Anandamide and endocannabinoid system: an attractive therapeutic approach for cardiovascular disease. (2018) pubmed
- Anandamide and other N-acylethanolamines: A class of signaling lipids with therapeutic opportunities. (2023) pubmed
- An Introduction to the Endogenous Cannabinoid System. (2016) pubmed
- Biosynthetic pathways of the endocannabinoid anandamide. (2007) pubmed
- Gut symbiont-derived anandamide promotes reward learning in honeybees by activating the endocannabinoid pathway. (2024) pubmed
- The conserved endocannabinoid anandamide modulates olfactory sensitivity to induce hedonic feeding in C. elegans. (2023) pubmed
- Anandamide transport. (2004) pubmed
- The endocannabinoid system. (2020) pubmed
- The endocannabinoid anandamide is an airway relaxant in health and disease. (2022) pubmed
- The endocannabinoid anandamide from immunomodulation to neuroprotection. Implications for multiple sclerosis. (2009) pubmed